Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization.

Pitre-Champagnat S, Leguerney I, Bosq J, Peronneau P, Kiessling F, Calmels L, Coulot J, Lassau N.

Invest Radiol. 2015 Apr;50(4):212-7. doi: 10.1097/RLI.0000000000000101.

PMID:
25275834
2.

Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.

Pöschinger T, Renner A, Eisa F, Dobosz M, Strobel S, Weber TG, Brauweiler R, Kalender WA, Scheuer W.

Invest Radiol. 2014 Jul;49(7):445-56. doi: 10.1097/RLI.0000000000000038.

PMID:
24598441
3.

Early quantitative evaluation of a tumor vasculature disruptive agent AVE8062 using dynamic contrast-enhanced ultrasonography.

Lavisse S, Lejeune P, Rouffiac V, Elie N, Bribes E, Demers B, Vrignaud P, Bissery MC, Brulé A, Koscielny S, Péronneau P, Lassau N.

Invest Radiol. 2008 Feb;43(2):100-11. doi: 10.1097/RLI.0b013e3181577cfc.

PMID:
18197062
4.

Contrast-enhanced ultrasonic parametric perfusion imaging in the evaluation of antiangiogenic tumor treatment.

Zhou JH, Zheng W, Cao LH, Liu M, Luo RZ, Han F, Wu PH, Li AH.

Eur J Radiol. 2012 Jun;81(6):1360-5. doi: 10.1016/j.ejrad.2011.01.099. Epub 2011 Feb 22.

PMID:
21345633
5.

Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study.

Lassau N, Bonastre J, Kind M, Vilgrain V, Lacroix J, Cuinet M, Taieb S, Aziza R, Sarran A, Labbe-Devilliers C, Gallix B, Lucidarme O, Ptak Y, Rocher L, Caquot LM, Chagnon S, Marion D, Luciani A, Feutray S, Uzan-Augui J, Coiffier B, Benastou B, Koscielny S.

Invest Radiol. 2014 Dec;49(12):794-800. doi: 10.1097/RLI.0000000000000085.

6.

In vitro evaluation of the impact of ultrasound scanner settings and contrast bolus volume on time-intensity curves.

Gauthier TP, Chebil M, Peronneau P, Lassau N.

Ultrasonics. 2012 Jan;52(1):12-9. doi: 10.1016/j.ultras.2011.06.003. Epub 2011 Jun 13.

PMID:
21722933
7.

Feasibility of Using Volumetric Contrast-Enhanced Ultrasound with a 3-D Transducer to Evaluate Therapeutic Response after Targeted Therapy in Rabbit Hepatic VX2 Carcinoma.

Kim J, Kim JH, Yoon SH, Choi WS, Kim YJ, Han JK, Choi BI.

Ultrasound Med Biol. 2015 Dec;41(12):3131-9. doi: 10.1016/j.ultrasmedbio.2015.07.031. Epub 2015 Sep 11.

PMID:
26365926
8.

Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.

Wang H, Hristov D, Qin J, Tian L, Willmann JK.

Radiology. 2015 Nov;277(2):424-34. doi: 10.1148/radiol.2015142824. Epub 2015 May 22.

9.

Assessment of quantitative perfusion parameters by dynamic contrast-enhanced sonography using a deconvolution method: an in vitro and in vivo study.

Gauthier M, Tabarout F, Leguerney I, Polrot M, Pitre S, Peronneau P, Lassau N.

J Ultrasound Med. 2012 Apr;31(4):595-608.

PMID:
22441917
10.

Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.

Egger C, Goertz RS, Strobel D, Lell M, Neurath MF, Knieling F, Scharf M.

Ultraschall Med. 2012 Dec;33(6):587-92. doi: 10.1055/s-0032-1325545. Epub 2012 Nov 15.

PMID:
23154871
11.

Contrast-enhanced US quantitatively detects changes of tumor perfusion in a murine breast cancer model during adriamycin chemotherapy.

Wang JW, Cao LH, Han F, Zheng W, Chen Y, Li AH, Zhou JH.

Acta Radiol. 2013 Oct;54(8):882-8. doi: 10.1177/0284185113488019. Epub 2013 May 12. Retraction in: Skjennald A. Acta Radiol. 2014 Oct;55(8):901-2.

PMID:
23761553
12.

Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.

Chen J, Qian T, Zhang H, Wei C, Meng F, Yin H.

Magn Reson Imaging. 2016 Feb;34(2):177-82. doi: 10.1016/j.mri.2015.10.013. Epub 2015 Oct 27.

PMID:
26518059
13.

A multiplicative model for improving microvascular flow estimation in dynamic contrast-enhanced ultrasound (DCE-US): theory and experimental validation.

Barrois G, Coron A, Payen T, Dizeux A, Bridal L.

IEEE Trans Ultrason Ferroelectr Freq Control. 2013 Nov;60(11):2284-94. doi: 10.1109/TUFFC.2013.6644733.

PMID:
24158285
14.

Study of Intrapatient Variability and Reproducibility of Quantitative Tumor Perfusion Parameters Evaluated With Dynamic Contrast-Enhanced Ultrasonography.

Lassau N, Coiffier B, Faivre L, Benatsou B, Bidault S, Girard E, Asselain B, Pitre-Champagnat S, Koscielny S.

Invest Radiol. 2017 Mar;52(3):148-154. doi: 10.1097/RLI.0000000000000324.

PMID:
28106614
15.

Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization.

Peronneau P, Lassau N, Leguerney I, Roche A, Cosgrove D.

Ultraschall Med. 2010 Aug;31(4):370-8. doi: 10.1055/s-0029-1245450. Epub 2010 Jun 24.

PMID:
20577941
16.

Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.

Zhao H, Xu R, Ouyang Q, Chen L, Dong B, Huihua Y.

Eur J Radiol. 2010 Feb;73(2):288-93. doi: 10.1016/j.ejrad.2009.05.043. Epub 2009 Jun 25.

PMID:
19559551
17.

Correlation of contrast-enhanced ultrasound with two distinct types of blood vessels for the assessment of angiogenesis in lewis lung carcinoma.

Zhuo J, Fu W, Liu S.

Ultraschall Med. 2014 Oct;35(5):468-72. doi: 10.1055/s-0033-1356194. Epub 2013 Dec 10.

PMID:
24327471
18.

Estimation of intra-operator variability in perfusion parameter measurements using DCE-US.

Gauthier M, Leguerney I, Thalmensi J, Chebil M, Parisot S, Peronneau P, Roche A, Lassau N.

World J Radiol. 2011 Mar 28;3(3):70-81. doi: 10.4329/wjr.v3.i3.70.

19.

Enhancement patterns and parameters of breast cancers at contrast-enhanced US: correlation with prognostic factors.

Wan CF, Du J, Fang H, Li FH, Zhu JS, Liu Q.

Radiology. 2012 Feb;262(2):450-9. doi: 10.1148/radiol.11110789.

PMID:
22282183
20.

Supplemental Content

Support Center